Semaglutide with glycine and B12 is a common combination
Moran, Claus Aagaard Nielsen, Mikkel Due Petersen, Lars Nygaard, David rsted, Christian Poulsen, Tina Secher Rasmussen, and Else Marie Agger (Novo Nordisk A/S, Denmark) for review of and input to the manuscript, and to Alexander Jones, PhD, CMPP TM and Sola Neunie, MSc, CMPP TM from AXON Communications (supported by Novo Nordisk) for writing assisstance
The FDA-approved dosing schedule for Ozempic is: Week 1-4: 0.25 mg dose once weekly for the first 4 weeks (starting dose)/ Week 5-8: 0.5 mg dose once weekly Week 9-12: 1 mg once weekly, if needed Week 13 onwards: 2 mg once weekly if further glycemic control is required
Tips for Week 1: Follow your weekly Semaglutide schedule as prescribed